Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Slagelse – page 2

89 clinical trials in Slagelse, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Slagelse at a glance
89
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

89 trials in Slagelse

Open in trial search

Efficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Lunsekimig
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Stomatitis+1

Recruiting

A study to compare the effectiveness of bupivacaine hydrochloride monohydrate and lidocaine hydrochloride for treating mouth sores in patients with head and neck cancer.

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bupivacaine hydrochloride monohydrate
  • Sponsor:OncoZenge AB

A study on the effectiveness of cagrilintide and semaglutide for weight management in children and adolescents with obesity

Investigational
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Colitis ulcerative+1

Recruiting

A study of mirikizumab levels in breast milk of breastfeeding women with ulcerative colitis or Crohn's disease

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.

Cardiac failure+1

Recruiting

Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Zenagamtide
  • Sponsor:Novo Nordisk A/S

Breast cancer+2

Recruiting

A Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Capivasertib
  • Sponsor:Relay Therapeutics Inc.

Comparison of remifentanil and rocuronium for improving video laryngoscopy assisted tracheal intubation in adult patients undergoing general anesthesia

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Rocuronium Bromide
  • Sponsor:Nordsjaellands Hospital

Study of datopotamab deruxtecan with platinum-based therapy compared to gemcitabine with platinum-based therapy in patients with advanced urothelial cancer after prior treatment

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Daiichi Sankyo Inc.

Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ferric Derisomaltose
  • Sponsor:Pharmacosmos A/S

Study of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Tezepelumab
  • Sponsor:AstraZeneca AB

Colitis ulcerative+1

Recruiting

Study on Vedolizumab and Ustekinumab for Patients with Crohn's Disease and Ulcerative Colitis

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ustekinumab
  • Sponsor:Odense University Hospital

Intensive care

Recruiting

Evaluation of enoxaparin, dalteparin, nadroparin, tinzaparin and human albumin in adults admitted to intensive care unit with acute critical illness

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Dalteparin Sodium
  • Sponsor:Region Hovedstaden

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Slagelse

What the registry says about research in the country

01 Cardiovascular Research

Comprehensive studies focusing on heart failure prevention and treatment of atherosclerotic cardiovascular disease. Research includes evaluation of innovative therapies for reducing major adverse cardiovascular events.

  • Heart Failure Management
  • Cardiovascular Disease Prevention
  • Atrial Fibrillation Treatment

Multiple trials investigating novel drug combinations and treatment approaches for various cardiac conditions.

02 Critical Care Medicine

Advanced research in intensive care focusing on treating critically ill patients and managing sepsis. Studies evaluate different antibiotic regimens and treatment protocols.

  • Sepsis Management
  • Emergency Care Protocols
  • Critical Illness Interventions

Investigations aim to improve outcomes in acute critical illness and emergency situations.

03 Neurological & Autoimmune Disorders

Clinical trials examining new treatments for multiple sclerosis and investigating therapeutic approaches for psoriatic arthritis and axial spondyloarthritis.

  • Multiple Sclerosis Treatment
  • Inflammatory Arthritis
  • Autoimmune Conditions

Focus on developing more effective therapies for chronic neurological and inflammatory conditions.

04 Oncology Research

Innovative studies in colorectal cancer treatment, including immunotherapy approaches and investigation of iron deficiency management in cancer patients.

  • Cancer Immunotherapy
  • Supportive Cancer Care
  • Treatment Optimization

Research aims to improve both cancer treatment outcomes and patient quality of life.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.